Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype

— Macrophage/microglia are activated after Traumatic brain injury (TBI), transform to inflammatory phenotype (M1) and trigger neuroinflammation, which provokes epileptogenesis. Interleukin-4 (IL-4) is a well-known drive of macrophage/microglia to the anti-inflammatory phenotype (M2). We tested effec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammation 2023-10, Vol.46 (5), p.1810-1831
Hauptverfasser: Radpour, Mozhdeh, Khoshkroodian, Bahar, Asgari, Tara, Pourbadie, Hamid Gholami, Sayyah, Mohammad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1831
container_issue 5
container_start_page 1810
container_title Inflammation
container_volume 46
creator Radpour, Mozhdeh
Khoshkroodian, Bahar
Asgari, Tara
Pourbadie, Hamid Gholami
Sayyah, Mohammad
description — Macrophage/microglia are activated after Traumatic brain injury (TBI), transform to inflammatory phenotype (M1) and trigger neuroinflammation, which provokes epileptogenesis. Interleukin-4 (IL-4) is a well-known drive of macrophage/microglia to the anti-inflammatory phenotype (M2). We tested effect of IL-4 on speed of epileptogenesis, brain expression of inflammatory and anti-inflammatory cytokines, and lesion size in TBI-injured male rats. Rats underwent TBI by Controlled Cortical Impact . Then 100 ng IL-4 was injected into cerebral ventricles. One day after TBI, pentylenetetrazole (PTZ) kindling started and development of generalized seizures was recorded. The lesion size, cell survival rate, TNF-α, TGF-β, IL-10, and Arginase1 (Arg1) was measured in the brain 6 h, 12 h, 24 h, 48 h, and 5 days after TBI. Astrocytes and macrophage/microglia activation/polarization was assessed by GFAP/Arg1 and Iba1/Arg1 immunostaining. TBI-injured rats were kindled by 50% less PTZ injections than control and sham-operated rats. IL-4 did not change kindling rate in sham-operated rats but inhibited acceleration of kindling rate in the TBI-injured rats. IL-4 decreased damage volume and number of destroyed neurons. IL-4 stopped TNF-α whereas upregulated TGF-β, IL-10, and Arg1 expressions. Iba1/Arg1 positive macrophage/microglia was notably increased 48 h after IL-4 administration. IL-4 suppresses TBI-induced acceleration of epileptogenesis in rats by directing TBI neuroinflammation toward an anti-inflammatory tone and inhibition of cell death.
doi_str_mv 10.1007/s10753-023-01843-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2821639029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2821639029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-d9c912614a5e86e731e0626952acfaddb0f93e8e2c09b8261a8ae3f1e86aed553</originalsourceid><addsrcrecordid>eNp9kc1u1DAQxyMEokvhBTggS1w4NKw_1k58LC1tV9qFCm3PkZNMsl4SJ7UdwT4WPAfimRi65UMcOPhr5jf_GeufJM8Zfc0ozeaB0UyKlHJcLF_g_iCZMZmJlMtMPUxmVCiaCq2zo-RJCDtKaa5z8Tg5EhmXmrLFLPm2dBF8B9NH68iCfIB6qiCQN97g-2o_gofPlY2mtJ2Ne2IapMnGm6k30VZk6XaT35NyT86HT85DO3UYdy3ZvLtIv385ITfjX8HlKmV0vrnE1NcTYlxNrocILlrTkXProbqj1qbyw7g1LczXFq9tZw2JA4lbIGtOTpFPrWs60-MMA3a_3oIbIs76NHnUmC7As_vzOLm5eLs5u0pX7y-XZ6ertBKZjGmtK824YgsjIVeQCQZUcaUlN1Vj6rqkjRaQA6-oLnMETW5ANAxhA7WU4jh5ddAd_XA7QYhFb0MFXWccDFMoeM6ZEppyjejLf9DdMHmH0yGVSSVyqhRS_EDhd0Pw0BSjt73x-4LR4qfXxcHrAr0u7rwuKBa9uJeeyh7q3yW_zEVAHICAKdeC_9P7P7I_AAXtuEU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2875638066</pqid></control><display><type>article</type><title>Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Radpour, Mozhdeh ; Khoshkroodian, Bahar ; Asgari, Tara ; Pourbadie, Hamid Gholami ; Sayyah, Mohammad</creator><creatorcontrib>Radpour, Mozhdeh ; Khoshkroodian, Bahar ; Asgari, Tara ; Pourbadie, Hamid Gholami ; Sayyah, Mohammad</creatorcontrib><description>— Macrophage/microglia are activated after Traumatic brain injury (TBI), transform to inflammatory phenotype (M1) and trigger neuroinflammation, which provokes epileptogenesis. Interleukin-4 (IL-4) is a well-known drive of macrophage/microglia to the anti-inflammatory phenotype (M2). We tested effect of IL-4 on speed of epileptogenesis, brain expression of inflammatory and anti-inflammatory cytokines, and lesion size in TBI-injured male rats. Rats underwent TBI by Controlled Cortical Impact . Then 100 ng IL-4 was injected into cerebral ventricles. One day after TBI, pentylenetetrazole (PTZ) kindling started and development of generalized seizures was recorded. The lesion size, cell survival rate, TNF-α, TGF-β, IL-10, and Arginase1 (Arg1) was measured in the brain 6 h, 12 h, 24 h, 48 h, and 5 days after TBI. Astrocytes and macrophage/microglia activation/polarization was assessed by GFAP/Arg1 and Iba1/Arg1 immunostaining. TBI-injured rats were kindled by 50% less PTZ injections than control and sham-operated rats. IL-4 did not change kindling rate in sham-operated rats but inhibited acceleration of kindling rate in the TBI-injured rats. IL-4 decreased damage volume and number of destroyed neurons. IL-4 stopped TNF-α whereas upregulated TGF-β, IL-10, and Arg1 expressions. Iba1/Arg1 positive macrophage/microglia was notably increased 48 h after IL-4 administration. IL-4 suppresses TBI-induced acceleration of epileptogenesis in rats by directing TBI neuroinflammation toward an anti-inflammatory tone and inhibition of cell death.</description><identifier>ISSN: 0360-3997</identifier><identifier>EISSN: 1573-2576</identifier><identifier>DOI: 10.1007/s10753-023-01843-0</identifier><identifier>PMID: 37259014</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Anti-Inflammatory Agents ; Astrocytes ; Biomedical and Life Sciences ; Biomedicine ; Brain - metabolism ; Brain Injuries, Traumatic - pathology ; Cell activation ; Cell death ; Cell size ; Cell survival ; Cytokines ; Epilepsy ; Genotype &amp; phenotype ; Glial fibrillary acidic protein ; Immunology ; Inflammation ; Interleukin 10 ; Interleukin 4 ; Interleukin-10 - metabolism ; Interleukin-4 - metabolism ; Internal Medicine ; Kindling ; Macrophages ; Macrophages - metabolism ; Male ; Microglia ; Microglia - metabolism ; Neuroinflammatory Diseases ; Pathology ; Pentylenetetrazole ; Pharmacology/Toxicology ; Phenotype ; Phenotypes ; Rats ; Rheumatology ; Seizures ; Transforming Growth Factor beta - metabolism ; Transforming growth factor-b ; Traumatic brain injury ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-α ; Ventricles (cerebral)</subject><ispartof>Inflammation, 2023-10, Vol.46 (5), p.1810-1831</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-d9c912614a5e86e731e0626952acfaddb0f93e8e2c09b8261a8ae3f1e86aed553</citedby><cites>FETCH-LOGICAL-c375t-d9c912614a5e86e731e0626952acfaddb0f93e8e2c09b8261a8ae3f1e86aed553</cites><orcidid>0000-0001-6315-6254 ; 0000-0003-2463-8087 ; 0000-0003-0603-2444 ; 0000-0003-1668-6820 ; 0000-0002-7634-7428</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10753-023-01843-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10753-023-01843-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37259014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Radpour, Mozhdeh</creatorcontrib><creatorcontrib>Khoshkroodian, Bahar</creatorcontrib><creatorcontrib>Asgari, Tara</creatorcontrib><creatorcontrib>Pourbadie, Hamid Gholami</creatorcontrib><creatorcontrib>Sayyah, Mohammad</creatorcontrib><title>Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype</title><title>Inflammation</title><addtitle>Inflammation</addtitle><addtitle>Inflammation</addtitle><description>— Macrophage/microglia are activated after Traumatic brain injury (TBI), transform to inflammatory phenotype (M1) and trigger neuroinflammation, which provokes epileptogenesis. Interleukin-4 (IL-4) is a well-known drive of macrophage/microglia to the anti-inflammatory phenotype (M2). We tested effect of IL-4 on speed of epileptogenesis, brain expression of inflammatory and anti-inflammatory cytokines, and lesion size in TBI-injured male rats. Rats underwent TBI by Controlled Cortical Impact . Then 100 ng IL-4 was injected into cerebral ventricles. One day after TBI, pentylenetetrazole (PTZ) kindling started and development of generalized seizures was recorded. The lesion size, cell survival rate, TNF-α, TGF-β, IL-10, and Arginase1 (Arg1) was measured in the brain 6 h, 12 h, 24 h, 48 h, and 5 days after TBI. Astrocytes and macrophage/microglia activation/polarization was assessed by GFAP/Arg1 and Iba1/Arg1 immunostaining. TBI-injured rats were kindled by 50% less PTZ injections than control and sham-operated rats. IL-4 did not change kindling rate in sham-operated rats but inhibited acceleration of kindling rate in the TBI-injured rats. IL-4 decreased damage volume and number of destroyed neurons. IL-4 stopped TNF-α whereas upregulated TGF-β, IL-10, and Arg1 expressions. Iba1/Arg1 positive macrophage/microglia was notably increased 48 h after IL-4 administration. IL-4 suppresses TBI-induced acceleration of epileptogenesis in rats by directing TBI neuroinflammation toward an anti-inflammatory tone and inhibition of cell death.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents</subject><subject>Astrocytes</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain - metabolism</subject><subject>Brain Injuries, Traumatic - pathology</subject><subject>Cell activation</subject><subject>Cell death</subject><subject>Cell size</subject><subject>Cell survival</subject><subject>Cytokines</subject><subject>Epilepsy</subject><subject>Genotype &amp; phenotype</subject><subject>Glial fibrillary acidic protein</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Interleukin 10</subject><subject>Interleukin 4</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-4 - metabolism</subject><subject>Internal Medicine</subject><subject>Kindling</subject><subject>Macrophages</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Neuroinflammatory Diseases</subject><subject>Pathology</subject><subject>Pentylenetetrazole</subject><subject>Pharmacology/Toxicology</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Rats</subject><subject>Rheumatology</subject><subject>Seizures</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transforming growth factor-b</subject><subject>Traumatic brain injury</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-α</subject><subject>Ventricles (cerebral)</subject><issn>0360-3997</issn><issn>1573-2576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1u1DAQxyMEokvhBTggS1w4NKw_1k58LC1tV9qFCm3PkZNMsl4SJ7UdwT4WPAfimRi65UMcOPhr5jf_GeufJM8Zfc0ozeaB0UyKlHJcLF_g_iCZMZmJlMtMPUxmVCiaCq2zo-RJCDtKaa5z8Tg5EhmXmrLFLPm2dBF8B9NH68iCfIB6qiCQN97g-2o_gofPlY2mtJ2Ne2IapMnGm6k30VZk6XaT35NyT86HT85DO3UYdy3ZvLtIv385ITfjX8HlKmV0vrnE1NcTYlxNrocILlrTkXProbqj1qbyw7g1LczXFq9tZw2JA4lbIGtOTpFPrWs60-MMA3a_3oIbIs76NHnUmC7As_vzOLm5eLs5u0pX7y-XZ6ertBKZjGmtK824YgsjIVeQCQZUcaUlN1Vj6rqkjRaQA6-oLnMETW5ANAxhA7WU4jh5ddAd_XA7QYhFb0MFXWccDFMoeM6ZEppyjejLf9DdMHmH0yGVSSVyqhRS_EDhd0Pw0BSjt73x-4LR4qfXxcHrAr0u7rwuKBa9uJeeyh7q3yW_zEVAHICAKdeC_9P7P7I_AAXtuEU</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Radpour, Mozhdeh</creator><creator>Khoshkroodian, Bahar</creator><creator>Asgari, Tara</creator><creator>Pourbadie, Hamid Gholami</creator><creator>Sayyah, Mohammad</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6315-6254</orcidid><orcidid>https://orcid.org/0000-0003-2463-8087</orcidid><orcidid>https://orcid.org/0000-0003-0603-2444</orcidid><orcidid>https://orcid.org/0000-0003-1668-6820</orcidid><orcidid>https://orcid.org/0000-0002-7634-7428</orcidid></search><sort><creationdate>20231001</creationdate><title>Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype</title><author>Radpour, Mozhdeh ; Khoshkroodian, Bahar ; Asgari, Tara ; Pourbadie, Hamid Gholami ; Sayyah, Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-d9c912614a5e86e731e0626952acfaddb0f93e8e2c09b8261a8ae3f1e86aed553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents</topic><topic>Astrocytes</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain - metabolism</topic><topic>Brain Injuries, Traumatic - pathology</topic><topic>Cell activation</topic><topic>Cell death</topic><topic>Cell size</topic><topic>Cell survival</topic><topic>Cytokines</topic><topic>Epilepsy</topic><topic>Genotype &amp; phenotype</topic><topic>Glial fibrillary acidic protein</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Interleukin 10</topic><topic>Interleukin 4</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-4 - metabolism</topic><topic>Internal Medicine</topic><topic>Kindling</topic><topic>Macrophages</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Neuroinflammatory Diseases</topic><topic>Pathology</topic><topic>Pentylenetetrazole</topic><topic>Pharmacology/Toxicology</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Rats</topic><topic>Rheumatology</topic><topic>Seizures</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transforming growth factor-b</topic><topic>Traumatic brain injury</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-α</topic><topic>Ventricles (cerebral)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Radpour, Mozhdeh</creatorcontrib><creatorcontrib>Khoshkroodian, Bahar</creatorcontrib><creatorcontrib>Asgari, Tara</creatorcontrib><creatorcontrib>Pourbadie, Hamid Gholami</creatorcontrib><creatorcontrib>Sayyah, Mohammad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Radpour, Mozhdeh</au><au>Khoshkroodian, Bahar</au><au>Asgari, Tara</au><au>Pourbadie, Hamid Gholami</au><au>Sayyah, Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype</atitle><jtitle>Inflammation</jtitle><stitle>Inflammation</stitle><addtitle>Inflammation</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>46</volume><issue>5</issue><spage>1810</spage><epage>1831</epage><pages>1810-1831</pages><issn>0360-3997</issn><eissn>1573-2576</eissn><abstract>— Macrophage/microglia are activated after Traumatic brain injury (TBI), transform to inflammatory phenotype (M1) and trigger neuroinflammation, which provokes epileptogenesis. Interleukin-4 (IL-4) is a well-known drive of macrophage/microglia to the anti-inflammatory phenotype (M2). We tested effect of IL-4 on speed of epileptogenesis, brain expression of inflammatory and anti-inflammatory cytokines, and lesion size in TBI-injured male rats. Rats underwent TBI by Controlled Cortical Impact . Then 100 ng IL-4 was injected into cerebral ventricles. One day after TBI, pentylenetetrazole (PTZ) kindling started and development of generalized seizures was recorded. The lesion size, cell survival rate, TNF-α, TGF-β, IL-10, and Arginase1 (Arg1) was measured in the brain 6 h, 12 h, 24 h, 48 h, and 5 days after TBI. Astrocytes and macrophage/microglia activation/polarization was assessed by GFAP/Arg1 and Iba1/Arg1 immunostaining. TBI-injured rats were kindled by 50% less PTZ injections than control and sham-operated rats. IL-4 did not change kindling rate in sham-operated rats but inhibited acceleration of kindling rate in the TBI-injured rats. IL-4 decreased damage volume and number of destroyed neurons. IL-4 stopped TNF-α whereas upregulated TGF-β, IL-10, and Arg1 expressions. Iba1/Arg1 positive macrophage/microglia was notably increased 48 h after IL-4 administration. IL-4 suppresses TBI-induced acceleration of epileptogenesis in rats by directing TBI neuroinflammation toward an anti-inflammatory tone and inhibition of cell death.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37259014</pmid><doi>10.1007/s10753-023-01843-0</doi><tpages>22</tpages><orcidid>https://orcid.org/0000-0001-6315-6254</orcidid><orcidid>https://orcid.org/0000-0003-2463-8087</orcidid><orcidid>https://orcid.org/0000-0003-0603-2444</orcidid><orcidid>https://orcid.org/0000-0003-1668-6820</orcidid><orcidid>https://orcid.org/0000-0002-7634-7428</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0360-3997
ispartof Inflammation, 2023-10, Vol.46 (5), p.1810-1831
issn 0360-3997
1573-2576
language eng
recordid cdi_proquest_miscellaneous_2821639029
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Anti-Inflammatory Agents
Astrocytes
Biomedical and Life Sciences
Biomedicine
Brain - metabolism
Brain Injuries, Traumatic - pathology
Cell activation
Cell death
Cell size
Cell survival
Cytokines
Epilepsy
Genotype & phenotype
Glial fibrillary acidic protein
Immunology
Inflammation
Interleukin 10
Interleukin 4
Interleukin-10 - metabolism
Interleukin-4 - metabolism
Internal Medicine
Kindling
Macrophages
Macrophages - metabolism
Male
Microglia
Microglia - metabolism
Neuroinflammatory Diseases
Pathology
Pentylenetetrazole
Pharmacology/Toxicology
Phenotype
Phenotypes
Rats
Rheumatology
Seizures
Transforming Growth Factor beta - metabolism
Transforming growth factor-b
Traumatic brain injury
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-α
Ventricles (cerebral)
title Interleukin 4 Reduces Brain Hyperexcitability after Traumatic Injury by Downregulating TNF-α, Upregulating IL-10/TGF-β, and Potential Directing Macrophage/Microglia to the M2 Anti-inflammatory Phenotype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin%204%20Reduces%20Brain%20Hyperexcitability%20after%20Traumatic%20Injury%20by%20Downregulating%20TNF-%CE%B1,%20Upregulating%20IL-10/TGF-%CE%B2,%20and%20Potential%20Directing%20Macrophage/Microglia%20to%20the%20M2%20Anti-inflammatory%20Phenotype&rft.jtitle=Inflammation&rft.au=Radpour,%20Mozhdeh&rft.date=2023-10-01&rft.volume=46&rft.issue=5&rft.spage=1810&rft.epage=1831&rft.pages=1810-1831&rft.issn=0360-3997&rft.eissn=1573-2576&rft_id=info:doi/10.1007/s10753-023-01843-0&rft_dat=%3Cproquest_cross%3E2821639029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2875638066&rft_id=info:pmid/37259014&rfr_iscdi=true